Moreover, the relationship between ZNF268 expression with T-stage (P < 0.001), N-stage (P > 0.050), M-stage (P = 0.080), pathologic stage (P < 0.001) and histologic grade (P < 0.001) was measured with the results indicating that low ZNF268 expression was accompanied with advanced tumor clinicopathological features (figure 1f-j and Table 1). Here, ZNF268 is linked to neoplasm.